HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful treatment of serpiginous choroiditis with alkylating agents.

AbstractOBJECTIVE:
To describe the management and long-term outcomes of patients with serpiginous choroiditis treated with alkylating agents.
DESIGN:
Retrospective, noncomparative case series.
PARTICIPANTS:
Nine patients with active, vision-threatening serpiginous choroiditis who had progressive inflammation while on steroids and/or immunosuppressive agents other than alkylating agents treated at three tertiary care uveitis referral centers.
METHODS:
Patients received systemic immunosuppression with an alkylating agent, either chlorambucil or cyclophosphamide. Prednisone also was given initially and was tapered and discontinued.
MAIN OUTCOME MEASURES:
Visual acuity, clinical disease activity, duration of treatment, duration of drug-free disease remission, and side effects of alkylating agent therapy.
RESULTS:
No patients had recurrences while on therapy. No further visual loss was encountered after starting the therapy. Six of the patients regained vision. All but two patients achieved prolonged drug-free remissions, ranging in duration between 15 and 96 months (median, 78 months). Side effects included transient bone marrow suppression, nausea, and fatigue. Secondary malignancy was encountered in one patient, whose carcinoma of the urinary bladder was treated successfully.
CONCLUSIONS:
Adequate immunosuppression with alkylating agents may favorably alter the long-term prognosis of patients with serpiginous choroiditis.
AuthorsEsen Karamursel Akpek, Douglas A Jabs, Howard H Tessler, Brian C Joondeph, C Stephen Foster
JournalOphthalmology (Ophthalmology) Vol. 109 Issue 8 Pg. 1506-13 (Aug 2002) ISSN: 0161-6420 [Print] United States
PMID12153803 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antineoplastic Agents, Alkylating
  • Immunosuppressive Agents
  • Chlorambucil
  • Cyclophosphamide
Topics
  • Adult
  • Aged
  • Antineoplastic Agents, Alkylating (therapeutic use)
  • Chlorambucil (therapeutic use)
  • Choroiditis (diagnosis, drug therapy)
  • Cyclophosphamide
  • Disease Progression
  • Female
  • Fluorescein Angiography
  • Follow-Up Studies
  • Humans
  • Immunosuppressive Agents (therapeutic use)
  • Male
  • Middle Aged
  • Retrospective Studies
  • Treatment Outcome
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: